Background Based on previous findings, we hypothesised that radiotherapy to the prostate
would improve overall survival in men with metastatic prostate cancer, and that the benefit …

Background STAMPEDE has previously reported that radiotherapy (RT) to the prostate
improved overall survival (OS) for patients with newly diagnosed prostate cancer with low …

Background Many trials are evaluating therapies for men with metastatic hormone-sensitive
prostate cancer (mHSPC). Objective To systematically review trials of prostate radiotherapy …

Purpose There is growing interest in the role of local therapies, including external beam
radiotherapy (RT), for men with metastatic prostate cancer (mPCa). We used the National …

Purpose: We assessed survival after radical prostatectomy, intensity modulated radiation
therapy or conformal radiation therapy vs no local therapy for metastatic prostate cancer …

Background Current standard of care for metastatic castration-sensitive prostate cancer
supplements androgen deprivation therapy with either docetaxel, second-generation …

Background Early chemotherapy might improve the overall outcomes of patients with
metastatic non-castrate (ie, hormone-sensitive) prostate cancer. We investigated the effects …

Background Innovations in imaging and molecular characterisation together with novel
treatment options have improved outcomes in advanced prostate cancer. However, we still …

Abstract Background: Metastatic prostate cancer (PCa) is associated with considerable
diminished overall survival (OS). Standard treatment for metastatic PCa has long been …

Objective-The purpose of the guidelines national committee ccAFU was to propose updated
french guidelines for prostate cancer. Methods-A Medline search was achieved between …